Skip to main content

Table 1 Results of cell count

From: In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events

Cell number per unit

Control

1 nM

MTX-concentration

10 nM

10 nM

10 nM

Day 1

mean

13.50

17.83

28.67

25.50

33.17

 

SD

4.76

5.74

13.55

9.01

7.49

 

95% CI

10.48-16.52

11.81-23.86

14.45-42.88

16.05-34.95

25.30-41.03

Day 3

mean

37.58

54.02

74.01

65.83

85.17

 

SD

15.72

19.22

18.24

9.04

12.07

 

95% CI

27.59-47.57

33.84-74.16

54.86-93.14

56.34-75.32

72.50-97.84

Day 6

mean

159.92

110.67

69.33

63.67

70.50

 

SD

47.86

15.85

19.63

7.23

10.21

 

95% CI

129.51-190.33

94.04-127.30

48.73-89.94

56.08-71.25

59.78-81.22

Day 8

mean

222.04

97.51

59.83

56.17

63.67

 

SD

40.72

18.08

23.09

12.70

12.31

 

95% CI

192.13-247.87

78.53-116.47

35.60-84.07

42.84-69.50

50.75-76.58

Day 10

mean

221.17

68.00

31.17

33.53

36.33

 

SD

51.30

30.68

7.71

16.79

6.22

 

95% CI

188.57-253.76

35.80-100.20

23.08-39.25

15.88-51.12

29.81-42.86

Day 14

mean

210.92

90.83

41.17

37.83

40.83

 

SD

55.25

49.06

8.09

16.52

11.48

 

95% CI

175.82-246.02

39.34-142.34

32.68-49.65

20.49-55.17

28.79-52.88

  1. SD = standard deviation; 95% CI = 95% confidence interval.